See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2015_GYRE_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 108,141,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 428,000 |
| 3 | remainder_Assets | 3,430,000 |
| 4 | LiabilitiesCurrent | 2,914,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,992,217 |
| 9 | ResearchAndDevelopmentExpense | 24,309,299 |
| 10 | remainder_Expenses | 7,000 |
| 11 | remainder_Revenues | 607,077 |
| 12 | remainder_NetIncome | 570,499 |
| 13 | remainder_ComprehensiveNetIncome | -94,016 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 111,999,000 |
| 1 | Liabilities | 2,914,000 |
| 2 | Expenses | 34,308,516 |
| 3 | Revenues | 607,077 |
| 4 | StockholdersEquity | 109,085,000 |
| 5 | NetIncome | -33,130,940 |
| 6 | ComprehensiveNetIncome | -33,177,948 |
| 7 | BaseVar | 75,246,554 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.56 |
| 9 | EconomicCapitalRatio | 4.07 |
Edgar->Model Mapping
Feature Distribution
Change over Time
